Clinical efficacy of tamsulosin and tadalafil in distal urethral stone passage: A randomized clinical trial
Abstract
Abstract:Purpose: To investigate the efficacy of tamsulosin in combination with tadalafil compared to tamsulosin alone in distal ureteral stones.
Methods: A total of 80 adult patients with single distal ureteral stones (5–12 mm) were included in this randomized open-label study. The patients were randomly and equally assigned into study and control groups. Study group (n = 40) received tamsulosin (0.4 mg) plus tadalafil (5 mg) daily, and control group received (n = 40) received tamsulosin (0.4 mg) alone. Follow-up was done for 20 days, and clinical parameters such as stone expulsion rate, time of expulsion, frequency of pain episodes, analgesic requirements, and side effects were compared between both groups. Categorical data were compared using chi-square test. Measurement data were compared using the independent sample t-test. P < 0.05 was considered statistically significant
Results: Stone expulsion rate was significantly higher, and mean stone expulsion time was significantly shorter in study group compared to control (p 0.05), with no major complications.
Conclusion: Tadalafil in combination with tamsulosin significantly increases expulsion rate, accelerates stone expulsion, reduces pain and analgesic use in patients with distal ureteral calculi without any significant increase in side effects.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 80 participants or records.
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.